For Scientific or Medical Collaboration, Please Contact Us: +6626507709

SC21 Team

Bio-Pharmaceutical Organization

Bringing cutting-edge biotechnology and innovative pharmaceutical products to the world

nicholas boyd gibbins, stem cell scientist, sc21 bio-pharma
Nicholas Boyd-Gibbins, MEng, PhD
  • Chief Scientific Officer, SC21 Bio-Pharma Laboratories (2023-present)
  • Chief Scientific Officer, Therabest Japan (2022-2023)
  • Scientific Director, StemCells21 (2020-2021)
  • Postdoctoral Researcher, Department of Clinical Application, CiRA, Kyoto University
  • PhD in Molecular Neuroscience, Faculty of Brain Sciences, University College London
  • MEng in Bioengineering, Queen Mary University, London


Nicholas is a scientist and bioengineer who has been leading industry R&D, translational, and biomanufacturing projects since 2020 as a Scientific Director, Head of Research, and Chief Scientific Officer in Thailand, Korea and Japan.
Originally training as a bioengineer at Queen Mary University, London, Nicholas first worked on iPSC engineering and epigenetic engineering in 2011. He then completed his PhD in molecular neuroscience at the Faculty of Brain Sciences, University College London, focusing on genetic and protein homeostasis, regeneration and ageing. He then worked as a postdoc in the Department for Clinical Application at the Centre for iPSC Research and Application (CiRA), Kyoto University, where he worked on stem cell and iPSC engineering, epigenetic engineering, cancer modeling, organoids, and neural stem cells.
His skills focus on team building, long-term strategic planning, translational pipeline design, biomanufacturing, cell engineering, iPSC technology, regenerative medicine, immunology, immunotherapy, cell therapy, stem cell biology, genetics, disease modeling, aging, cancer and neuroscience.

Dr. Thanakorn Pungsrinont (Map) PhD

Scientific and Manufacturing Director

Suttinee kummanochat (Ploy)

Production Assistant

SC21 Founders

Paul Collier

Co-Founder & Managing Director

mesenchymal stem cells, MSCs, MSC, umbilical cord MSCs, Adipose MSCs, Bone Marrow MSCs, MSC Culture,

Sergejs Dmitrijevs